The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature

Overview of attention for article published in BMC Cancer, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 2,425 followers.

Co-first author!! Wow, so thankful for this opportunity. I hope you guys consider it an interesting article! #uvealmelanoma #melatonin #NKS #KI #research Link: https://t.co/XLzyBChAnu

The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature. https://t.co/C89Pg3hwqR https://t.co/WuSaVPtlyp

New article: The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature https://t.co/FaAsZstxHp #livercancer #oncology https://t.co/nfH8ltcrYo

New article: The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature https://t.co/fWUJaNzTLm #melanoma #oncology https://t.co/rRCRagu1B0

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.